期刊文献+

恶性嗜铬细胞瘤的诊断进展 被引量:1

原文传递
导出
摘要 恶性嗜铬细胞瘤是较少见肿瘤,早期诊断极困难。而对良、恶性嗜铬细胞瘤治疗策略的选取截然不同,故早期诊断恶性嗜铬细胞瘤及评估嗜铬细胞瘤的恶性潜能极其重要。本文就当前恶性嗜铬细胞瘤分子生物学及影像学研究综述其诊断进展。
出处 《国际泌尿系统杂志》 2013年第4期536-539,共4页 International Journal of Urology and Nephrology
关键词 嗜铬细胞瘤
  • 相关文献

参考文献29

  • 1De Toma G, Letizia C, Cavallaro G, et al. Malignant pheochromo- cytoma. Personal experience, review of the literature. Ann ltal Chir,2002,73 (4) :413 - 8 ;discussion 418 -419. 被引量:1
  • 2Rao F, Keiser HR, OConnor DT. Malignant pheechromecytoma. Chromaffin granule transmitters and response to treatment. Hyper- tension, 2000,36(6) :1045 - 1052. 被引量:1
  • 3Portela - Gomes GM, Stridsberg M, Grimelius L, et al. Expression of ehromogranins A, B, and C (secretogranin II) in human adre- nal medulla and in benign and malignant pheochromecytomas An study with region - specific antibodies. AP- MIS, 2004,112(10) :663 -673. 被引量:1
  • 4Scholz T, Schulz C, Klose S, et al. Diagnostic management of be- nign and malignant pheochromocytoma. Exp CIin Endocrinol Dia- betes, 2007,115(3) :155 - 159. 被引量:1
  • 5Ahlman H. Malignant pheechromecytoma: state of the field with future projections. Ann N Y Acad Sci, 2006,1073:449 -464. 被引量:1
  • 6Boltze C, Mundschenk J, Unger N, et al. Expression profile of the telomeric complex discriminates between benign and malignant pheechromecytoma. J Clin Endocrinol Metab, 2003,88 ( 9 ) : 4280 - 4286. 被引量:1
  • 7Kubota Y, Nakada T, Sasagawa I, et al. Elevated levels of telom-erase activity in malignant pheochremocytoma. Cancer, 1998,82 (1) :176 -179. 被引量:1
  • 8Luo Z, Li J, Qin Y, et al. Differential expression of human telom- erase catalytic subunit mRNA by in situ hybridization in pheochro- mocytomas. Endocr Pathol, 2006,17 (4) :387 - 398. 被引量:1
  • 9刘彤华,陈原稼,武莎菲,高洁,蒋卫君,卢朝辉,关键,魏拴增,罗玉凤,曹金玲,万建伟.良性和恶性嗜铬细胞瘤的区别[J].中华病理学杂志,2004,33(3):198-202. 被引量:29
  • 10Koch CA, Vortmeyer AO, Diallo R, et al. Survivin: a novel neu- roendocrine marker for pheochromocytoma. Eur J Endocrinol, 2002,146(3 ) :381 - 388. 被引量:1

二级参考文献28

  • 1李汉忠,黄钟明,毛全宗,曾正培,苗齐,张抒扬.心脏嗜铬细胞瘤三例报告[J].中华泌尿外科杂志,2005,26(8):512-515. 被引量:5
  • 2闫朝丽,曾正陪,童安莉,卢琳,李明,周亚茹,张晶.嗜铬细胞瘤良、恶性鉴别的临床分析[J].中华医学杂志,2005,85(43):3086-3089. 被引量:10
  • 3Yeo H, Roman S. Pheochromocytoma and functional paraganglioma. Curr Op in Oncol, 2005, 17:13- 18. 被引量:1
  • 4Salmenkivi K, Heikkila P, Haglund C, et al. Malignancy in pheochromocytomas. APMIS, 2004, 112:551- 559. 被引量:1
  • 5Lenders JW, Eisenhofer G, Marmelli M, et al. Pheochromocytoma. Lancet, 2005, 366: 665-675. 被引量:1
  • 6Kopf D, Goretzki PE, Lehnert H, et al. Clinical management of malignant adrenal tumors. Cancer Res Clin Oncol, 2001, 127: 143 -155. 被引量:1
  • 7Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms :a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol, 2002, 26: 551- 566. 被引量:1
  • 8Januszewicz A, Neumann HP, Lon I, et al. Incidence and clinical relevance of RET proto oncogene germline mutations in pheochromocytoma patients. J Hypertens, 2000, 18: 1019-1023. 被引量:1
  • 9Taylor RL, Singh RJ. Validation of liquid chromatography tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrin for screening of pheochromocytoma. Clin Chem, 2002, 48: 533-539. 被引量:1
  • 10Opocher G, Schiavi F, Conton P, et at. Clinical and genetic aspects of pheochromocytoma. Horm Res, 2003, 59(Suppl 1): 56-61. 被引量:1

共引文献32

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部